Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

PHASE3CompletedINTERVENTIONAL

Enrollment

192

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis

Interventions

BIOLOGICAL

DTPw-HBV/Hib-MenAC conjugate vaccine

Trial Locations (4)

GSK Investigational Site, Brits

GSK Investigational Site, Brits

GSK Investigational Site, Centurion

GSK Investigational Site, Ga-Rankuwa